MetLife, Inc.

NYSE:MET 株式レポート

時価総額：US$53.6b

MetLife 将来の成長

Future 基準チェック /16

MetLife利益と収益がそれぞれ年間13.1%と4.3%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に16% 16.6%なると予測されています。

主要情報

13.1%

収益成長率

16.64%

EPS成長率

Insurance 収益成長2.0%
収益成長率4.3%
将来の株主資本利益率16.04%
アナリストカバレッジ

Good

最終更新日26 May 2026

今後の成長に関する最新情報

Recent updates

Seeking Alpha • May 24

MetLife: Time To Go Long The Common Shares And 6.35% Yielding Preferreds

Summary MetLife delivers robust adjusted income, supporting a bullish stance on common shares and fixed-rate preferreds. MET's preferred dividend payout ratio remains low, with $24.5B in common equity providing strong downside protection for preferred holders. Series A floating-rate preferreds yield 5.45%-5.5%, attractive if short-term rates rise, but fixed-rate Series F offers a higher current yield. I rate MET common and Series F preferreds as a "buy," maintaining "hold" on Series A preferreds pending a significant SOFR increase. Read the full article on Seeking Alpha
ナラティブの更新 • May 03

MET: Share Repurchases And Dividend Increases Will Support Future Upside Potential

Analysts have slightly adjusted their fair value estimate for MetLife, nudging the implied price target from about $89.06 to $89.31. This reflects modest tweaks to assumptions around the discount rate, long term revenue growth, profit margin and future P/E multiples.
ナラティブの更新 • Apr 17

MET: Share Repurchases Following Index Exit Will Support Future Upside Potential

Analysts have slightly reduced their MetLife fair value estimate to $89.06 from $90.50, reflecting minor adjustments to assumptions for the discount rate, revenue growth, profit margin, and future P/E ratio that refine their outlook for the shares. What's in the News MetLife has been dropped from the S&P 100 index, which may influence how some index funds and benchmarks gain exposure to the stock (Key Developments).
ナラティブの更新 • Apr 01

MET: Share Repurchases And Index Exit Will Shape Future Upside Potential

Analysts have trimmed their average MetLife price target slightly to $90.50 from $90.73, citing updated views on revenue growth, profit margins, and future P/E assumptions. What's in the News MetLife, Inc.
ナラティブの更新 • Mar 18

MET: Share Repurchases Will Support Future Upside Potential

Analysts have slightly adjusted their price target for MetLife to $90.73 from $90.93, reflecting updated views on discount rates, revenue growth, profit margins, and future price-to-earnings (P/E) assumptions. What's in the News MetLife reported that from October 1, 2025 to January 31, 2026 it repurchased 7,608,263 shares, representing 1.15% of shares, for a total of US$600 million under its current buyback program (Key Developments).
ナラティブの更新 • Mar 04

MET: Buybacks And Retirement Income Agreements Will Drive Future Upside

Analysts have trimmed their price target on MetLife to about $90.93 from roughly $92.93. This reflects updated views on slightly lower expected revenue growth, a modestly softer profit margin, a higher discount rate, and a largely unchanged future P/E assumption.
ナラティブの更新 • Dec 16

MET: Retirement Income Agreements Will Drive Future Upside In Earnings Power

Analysts have marginally reduced their price target on MetLife to approximately 92.93 dollars from 93 dollars, citing a slightly higher assumed discount rate. This more than offsets modest improvements in forecast profit margins and valuation multiples.
ナラティブの更新 • Nov 07

MET: Revenue Will Advance On New Retirement Income And Employee Support Agreements

Analysts have slightly reduced their price target for MetLife from $93.33 to $93.00, reflecting minor adjustments to discount rate and profit margin assumptions. They maintain a positive outlook on revenue growth.
ナラティブの更新 • Oct 24

Digital Expansion And Employee Support Benefits Will Drive Outperformance Ahead

Analysts have modestly raised their price target for MetLife, increasing it from $93.00 to $93.33 per share. They cited slight improvements in projected revenue growth and profit margins as the reason for the adjustment.
ナラティブの更新 • Oct 09

International Demand And Digital Transformation Will Fuel Success

Analysts have raised their fair value estimate for MetLife from $91.86 to $93.00. This reflects slight adjustments to discount rates and growth assumptions.
ナラティブの更新 • Sep 04

International Demand And Digital Transformation Will Fuel Success

With no change in revenue growth forecasts or discount rate, MetLife’s fair value estimate remains steady at $91.86. What's in the News MetLife will redeem all outstanding shares of its 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G, at $1,000 per share; dividends of $19.250 per share will be paid separately, and all further dividends cease post-redemption.
分析記事 • Jun 11

It's Unlikely That MetLife, Inc.'s (NYSE:MET) CEO Will See A Huge Pay Rise This Year

Key Insights MetLife's Annual General Meeting to take place on 17th of June Salary of US$1.50m is part of CEO Michel...
Seeking Alpha • Feb 11

MetLife: Double-Digit EPS Growth With A Single-Digit P/E, Strong Chart

Summary MetLife, Inc. is rated a buy due to its solid value, above-market dividend yield, and favorable technical chart despite recent earnings misses. Insurance stocks, including MET, have lagged behind the Financials sector and S&P 500, with premium increases expected to slow as consumers react to rising costs. MET's 2025 outlook is positive, with analysts forecasting over 17% EPS growth and 5%-6% revenue growth, despite recent underperformance in certain segments. Key risks include lower stock prices, falling interest rates, and regulatory challenges, but MET's strong investment income and share buybacks are positive factors. Read the full article on Seeking Alpha
Seeking Alpha • Nov 26

MetLife Upgraded To Buy As Financials And Insurance Show Further Upside Potential

Summary MetLife stock gets upgraded to a buy, from my prior hold rating, as indicators point to further share price potential in the financials sector, as well as the insurance subsector. Data points to future continued demand for annuities and life insurance, and MetLife has in Q3 achieved new organic customer growth in 2 key businesses. Although its dividend yield is not stellar vs. peers, it has a 10-year track record of proven dividend growth, something it has potential to continue. Even though it is trading at a 10-year high, it remains undervalued on P/E and EV/EBITDA vs. peers, so continues to present a buy opportunity. Read the full article on Seeking Alpha
Seeking Alpha • Sep 23

MetLife: One Of The Best Life Insurance Stocks

Summary MetLife's strong financial performance, with a 17.5% increase in adjusted EPS and a 15.2% rise in book value, makes it an attractive investment. Despite comparable performance to Aflac, MetLife's lower valuation offers better value for shareholders. MetLife's growing dividend yield and robust share buyback program enhance shareholder value, with ample cash reserves supporting future buybacks. Risks include potential commercial real estate portfolio defaults and market volatility, but MetLife's strong fundamentals and attractive valuation make it a compelling choice. Read the full article on Seeking Alpha
Seeking Alpha • Jul 09

Higher For Longer? Consider MetLife's Preferred Shares With A 6.6% Yield

Summary MetLife's preferred shares, particularly the Series A with floating dividends, offer potential for investors in a 'higher for longer' inflation and interest rate environment. MetLife's strong financial performance in Q1 2021, with net profit covering preferred dividends by less than 8%. Series A preferred shares have a minimum 4% floor for dividends, with potential for higher yields based on 3 month SOFR rate adjustments. Read the full article on Seeking Alpha
Seeking Alpha • Jun 26

MetLife Looks Like An Undervalued Property In An Unpopular Neighborhood

Summary MetLife shares have outperformed peers, but life insurance stocks have not really been in favor given concerns about CRE losses and rate cuts. Higher rates have allowed MetLife to reprice its investment portfolio at higher rates and sell more spread products, and the benefits will last even as rates fall. There are understandable concerns about MetLife's CRE exposure (office in particular), as the insurer is overweight here, but losses will take years to materialize and can be absorbed. MetLife's focus on profitable core businesses like group life and health, pension risk transfer, and international markets should lead to steady growth and returns for investors. This is something of a contrarian call given weak sector sentiment, but MetLife's differentiated model and ability to out-earn its cost of equity should drive outperformance. Read the full article on Seeking Alpha
Seeking Alpha • Apr 18

MetLife: Healthy But Lacks Clear Advantages

Summary MetLife has experienced a decade of light shrinking instead of growth. This started as early as 2015 and was attributed to increased competition and a decrease in annuity sales, but this never seemed to improve. With their current size, competitive hurdles, and lack of clear targets for growth internationally, shares of MET will likely only give mediocre returns at best. Read the full article on Seeking Alpha

業績と収益の成長予測

NYSE:MET - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/202887,2256,647N/AN/A6
12/31/202783,3036,2674,800N/A9
12/31/202679,2615,7874,600N/A7
3/31/202677,5843,43415,51715,517N/A
12/31/202577,0793,17317,09217,092N/A
9/30/202571,9323,63414,62714,627N/A
6/30/202573,0114,09115,22915,229N/A
3/31/202573,4944,30516,53216,532N/A
12/31/202470,9824,22614,59814,598N/A
9/30/202471,3403,56115,16915,169N/A
6/30/202468,7672,70814,47514,475N/A
3/31/202467,5702,16614,02314,023N/A
12/31/202366,9011,38013,72113,721N/A
9/30/202363,4792,35510,84010,840N/A
6/30/202369,8963,03111,67511,675N/A
3/31/202368,7473,54213,03013,030N/A
12/31/202268,7645,09913,04413,044N/A
9/30/202273,2514,72616,08316,083N/A
6/30/202267,8735,14915,27915,279N/A
3/31/202270,9237,63413,14013,140N/A
12/31/202168,6886,65412,34712,347N/A
9/30/202170,4095,30112,40912,409N/A
6/30/202169,5194,41312,69612,696N/A
3/31/202165,0941,11511,28811,288N/A
12/31/202067,8425,19111,63911,639N/A
9/30/202065,5675,60311,66711,667N/A
6/30/202068,2307,12212,02012,020N/A
3/31/202071,6288,73813,56113,561N/A
12/31/201969,6205,721N/A13,786N/A
9/30/201968,1397,195N/A9,906N/A
6/30/201965,7505,923N/A9,293N/A
3/31/201969,4385,084N/A12,514N/A
12/31/201867,9414,982N/A11,738N/A
9/30/201868,1125,244N/A12,487N/A
6/30/201867,9805,235N/A13,688N/A
3/31/201862,1195,197N/A11,481N/A
12/31/201762,3084,893N/A12,283N/A
9/30/201759,2631,893N/A15,876N/A
6/30/201758,9082,044N/A14,069N/A
3/31/201757,2632,229N/A14,959N/A
12/31/201660,7323,481N/A14,774N/A
9/30/201665,2094,994N/A13,733N/A
6/30/201667,2555,169N/A13,445N/A
3/31/201669,9525,219N/A13,356N/A
12/31/201561,2573,891N/A14,052N/A
9/30/201571,8885,857N/A14,953N/A
6/30/201572,6776,724N/A16,343N/A

アナリストによる今後の成長予測

収入対貯蓄率: METの予測収益成長率 (年間13.1% ) は 貯蓄率 ( 3.5% ) を上回っています。

収益対市場: METの収益 ( 13.1% ) US市場 ( 16.8% ) よりも低い成長が予測されています。

高成長収益: METの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: METの収益 ( 4.3% ) US市場 ( 11.8% ) よりも低い成長が予測されています。

高い収益成長: METの収益 ( 4.3% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: METの 自己資本利益率 は、3年後には低くなると予測されています ( 16 %)。

成長企業の発掘

7D

1Y

7D

1Y

7D

1Y

企業分析と財務データの現状

データ最終更新日（UTC時間）
企業分析2026/05/27 23:23
終値2026/05/27 00:00
収益2026/03/31
年間収益2025/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

MetLife, Inc. 9 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。32

アナリスト機関
Jacob KilsteinArgus Research Company
Jay GelbBarclays
Taylor ScottBarclays